Chin Yang Chem (051630) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Chin Yang Chem stock KRW 1,174, price KRW 3,500, that is 66.4% below the price, quality 34 out of 100. Rating: strongly overvalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range 919.00 KRW – 7,610 KRW · fair‑value band 681.24 KRW – 1,349 KRW · the 3,500 KRW price screens above the 1,174 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Chin Yang Chem in your weekly email
Every Wednesday you see whether Chin Yang Chem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Chinyang Chemical Corporation manufactures and sells chemical products in South Korea.
Show moreShow less
It offers floor coverings for residential and commercial purposes; artificial leather for car seats, door trims, consoles, and headrest applications, as well as furniture; and tarpaulin for Drapery, windbreak, awning, simple tent, car shelter, beach umbrellas, livestock use, and various covers.
The company was founded in 1963 and is headquartered in Ulsan, South Korea. ChinYang Chemical Corporation operates as a subsidiary of Jinyang Holdings Corp.
Stock analysis
Chin Yang Chem (051630) currently trades at 3,500 KRW, while our model-based Fair Value estimate is 1,174 KRW, 66% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of 1,318 KRW per share, and 0 of the 8 models we run sit above the 3,500 KRW price.
Bear case: the Earnings-Based group reads lowest at 351.45 KRW, and 8 of the 8 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 681.24 KRW (bear) to 1,349 KRW (bull), the price of 3,500 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Chin Yang Chem reported revenue of 18.6B KRW in FY2025 versus 34.8B KRW in FY2021, a compound −14.5%/yr. Reported net income was 896M KRW in FY2025.
Key figures
Market cap 74.2B KRW (≈ $54.9M) Micro · P/E ratio 25.4 · P/S ratio 2.36 · EPS (TTM) 83.34 KRW · Net margin 9.3% · Return on equity 4.6% · Return on assets (EBIT) −4.8% (5-year average) · Operating margin −3.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 26 out of 100 (medium confidence).
What moves the price
The share trades about 14% below its 52-week high and 281% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at −66%, 051630 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (351.45 KRW to 3,183 KRW). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear681.24 KRWFair Value 1,174 KRWBull1,349 KRW
Price 3,500 KRW · Downside -66.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (71.47 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.14/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−24.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−15.6%
Start year 2020 (pandemic). Over 10 years: −12.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−9.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−9.3%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−9.3% vs −9.1%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.1% → −4%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 16.7%/yr over ~7Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 340 stocks
Beats the industry median on 1/12 measures
Overall it trails its industry peers.
Valuation
Quality Score34 · Bottom 25%
Fair Value upside−66.4% · Bottom 25%
Profitability
Return on equity (12 months)4.6% · Below median
Return on assets1.1% · Below median
Net margin (12 months)9.3% · Above median
Operating margin (12 months)−3.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−2.1% · Bottom 25%
Balance sheet
Debt / equity0.88× · Highest 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
P/E (12 months)25.4× · Pricier than median
P/B1.87× · Pricier than median
P/S (12 months)3.91× · Priciest 25%
EV/EBITDA63.0× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 9
FUTURE (revenue growth)0· sector 67
PAST (return on equity)18· sector 24
HEALTH (low debt)56· sector 94
DIVIDEND (yield)0· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Chin Yang Chem Fair Value". https://www.fairvalue-calculator.com/stock/051630
Frequently asked questions
Is Chin Yang Chem (051630) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 1,174 KRW versus a price of 3,500 KRW, about 66% lower (overvalued).
What is the fair value of 051630?
Our model-based fair value for Chin Yang Chem is 1,174 KRW (as of Nov 7, 2026), built from audited fundamentals. The current price: 3,500 KRW.
What is the quality score of 051630?
Chin Yang Chem has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Chin Yang Chem (051630)?
Our model-based price target is the fair value of 1,174 KRW (as of Nov 7, 2026) from 9 valuation models. Cautious scenario 681.24 KRW, optimistic scenario 1,349 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Chin Yang Chem stock forecast for 2026?
Our models put fair value at 1,174 KRW, about 66% lower versus a price of 3,500 KRW (overvalued). Cautious scenario 681.24 KRW, optimistic scenario 1,349 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Chin Yang Chem (051630)?
Chin Yang Chem reported trailing-twelve-month revenue of about 19.0B KRW (latest available figure, as of Nov 7, 2026).
What is the intrinsic value of Chin Yang Chem (051630)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Chin Yang Chem it is 1,174 KRW per share (as of Nov 7, 2026), against a price of 3,500 KRW. It is the blended result of 9 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Chin Yang Chem stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 051630 trades above its calculated fair value: price 3,500 KRW, fair value 1,174 KRW, a gap of about −66% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 051630?
No. The price is what the market pays today (3,500 KRW); the fair value is what the company's own numbers justify (1,174 KRW). For Chin Yang Chem the two are 2,326 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Chin Yang Chem worth?
The market values Chin Yang Chem at about 74.2B KRW (market capitalisation, as of Nov 7, 2026). Per share that is 3,500 KRW; our models calculate a fair value of 1,174 KRW per share.
What do the bullish and bearish scenarios say about 051630?
Our models span a range for Chin Yang Chem: cautious scenario 681.24 KRW, base 1,174 KRW, optimistic 1,349 KRW per share (as of Nov 7, 2026, price 3,500 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 051630?
Chin Yang Chem trades at a price-to-earnings ratio of 25.4 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1,174 KRW is built from several models across several years. Other multiples: P/B 1.9, P/S 3.9, EV/EBITDA 63.0.
How solid is the balance sheet of Chin Yang Chem (051630)?
Balance-sheet figures for Chin Yang Chem (as of Nov 7, 2026): return on equity 4.6%, debt of 0.88 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is 051630 from its 52-week high?
Chin Yang Chem trades at 3,500 KRW, about 14% below its 52-week high of 4,080 KRW and 281% above the low of 919.00 KRW (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 1,174 KRW is for.
Which stocks are comparable to Chin Yang Chem?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Dow Inc, Ningxia Baofeng Energy Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Chin Yang Chem stock attractive at the current price?
The data as of Nov 7, 2026: price 3,500 KRW, calculated fair value 1,174 KRW (−66%), Quality Score 34/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 051630 calculated?
We run Chin Yang Chem through 9 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 1,174 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Chin Yang Chem itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Chin Yang Chem (051630)?
The closing price on Nov 9, 2026 was 3,500 KRW. Our model-based fair value is 1,174 KRW, about 66% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Chin Yang Chem right now?
The price sits above even our optimistic bull case (1,349 KRW). The favourable scenario is already priced in. Weak quality (34/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (681.24 KRW to 1,349 KRW) leaves room in how you read the outcome.
Key figures of Chin Yang Chem
How large is the market capitalisation of Chin Yang Chem (051630)?
The market capitalisation of Chin Yang Chem is 74.2B KRW (≈ $54.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Chin Yang Chem (051630)?
The price-to-sales ratio of Chin Yang Chem is 2.36 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Chin Yang Chem (051630)?
Earnings per share at Chin Yang Chem are 83.34 KRW (price ÷ EPS = P/E 25.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Chin Yang Chem (051630)?
The net margin of Chin Yang Chem is 9.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Chin Yang Chem (051630)?
The return on equity (ROE) of Chin Yang Chem is 4.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Chin Yang Chem (051630)?
On an EBIT basis the return on assets of Chin Yang Chem is −4.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Chin Yang Chem (051630)?
The operating margin of Chin Yang Chem is −3.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Chin Yang Chem (051630)?
Revenue at Chin Yang Chem is growing −2.1% versus a year earlier (3y avg −13.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Chin Yang Chem (051630)?
Earnings per share at Chin Yang Chem are growing +449% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Chin Yang Chem (051630) generate?
The free cash flow of Chin Yang Chem is −1.1B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Chin Yang Chem (051630) carry?
The net debt of Chin Yang Chem is 11.7B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Chin Yang Chem in the live analysis
One click puts Chin Yang Chem on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 7, 2026